Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein

Experimental Neurology

Volumn 192, Issue 2, 2005, Pages 274-287

  Frasier, M ^a   Walzer, M ^a   McCarthy, L ^a   Magnuson, D ^a   Lee, J M ^a   Haas, C ^b   Kahle, P ^b   Wolozin, B ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aggregation; Astrocytosis; c jun Kinase; CDK5; Fibrillization; GSK 3 ; JNK; Lewy body; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN; PROTEIN TAU; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION;

EID: 14844311246     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.07.016     Document Type: Article

References (73)

1. B. Bu, H. Klunemann, K. Suzuki, J. Li, T. Bird, L.W. Jin, and I. Vincent Niemann-Pick disease type C yields possible clue for why cerebellar neurons do not form neurofibrillary tangles Neurobiol. Dis. 11 2002 285 297
2. V. Charles, E. Mezey, P.H. Reddy, A. Dehejia, T.A. Young, M.H. Polymeropoulos, M.J. Brownstein, and D.A. Tagle alpha-Synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models Neurosci. Lett. 289 2000 29 32
3. P. Choi, N. Golts, H. Snyder, L. Petrucelli, M. Chong, J. Hardy, D. Sparkman, E. Cochran, J. Lee, and B. Wolozin Co-association of parkin and α-synuclein NeuroReport 12 2001 2839 2844
4. K. Conway, J. Harper, and P. Lansbury Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease Nat. Med. 4 1998 1318 1320
5. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Jr. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci.U. S. A. 97 2000 571 576
6. M. DiFiglia, E. Sapp, K. Chase, S. Davies, G. Bates, J. Vonsattel, and N. Aronin Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993
7. G. Drewes, B. Lichtenberg-Kraag, F. Doring, E. Mandelkow, J. Biernat, J. Goris, M. Doree, and E. Mandelkow Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state EMBO J. 11 1992 2131 2138
8. J.E. Duda, B.I. Giasson, M.E. Mabon, D.C. Miller, L.I. Golbe, V.M. Lee, and J.Q. Trojanowski Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred Acta Neuropathol. (Berl.) 104 2002 7 11
9. S. Engelender, Z. Kaminsky, X. Guo, A. Sharp, R. Amaravi, J. Kleiderlein, R. Margolis, J. Troncoso, A. Lanahan, P. Worley, V. Dawson, T. Dawson, and C. Ross Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions Nat. Genet. 22 1999 110 114
10. X. Fang, S.X. Yu, Y. Lu, R.C. Bast Jr., J.R. Woodgett, and G.B. Mills Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A Proc. Natl. Acad. Sci.U. S. A. 97 2000 11960 11965
11. M.B. Feany, and W.W. Bender A Drosophila model of Parkinson's disease Nature 404 2000 394 398
12. M.S. Forman, M.L. Schmidt, S. Kasturi, D.P. Perl, V.M. Lee, and J.Q. Trojanowski Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam Am. J. Pathol. 160 2002 1725 1731
13. R.A. Furlong, Y. Narain, J. Rankin, A. Wyttenbach, and D.C. Rubinsztein alpha-Synuclein overexpression promotes aggregation of mutant huntingtin Biochem. J. 346 Pt. 3 2000 577 581
14. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, F. Gillespie, T. Guido, S. Hagopian, M. Johnson, K. Wood, K. Khan, M. Lee, P. Leibowitz, I. Lieberburg, S. Little, E. Masliah, L. McConlogue, M. Montoya-Zavala, L. Mucke, L. Paganini, E. Penniman, M. Power, D. Schenk, P. Seubert, B. Snyder, F. Soriano, H. Tan, J. Vitale, S. Wadsworth, B. Wolozin, and J. Zhao Development of neuropathology similar to Alzheimer's disease in transgenic mice overexpressing the 717V-F β-amyloid precursor protein Nature 373 1995 523 527
15. B.I. Giasson, J.E. Duda, S.M. Quinn, B. Zhang, J.Q. Trojanowski, and V.M. Lee Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 2002 521 533
16. B.I. Giasson, M.S. Forman, M. Higuchi, L.I. Golbe, C.L. Graves, P.T. Kotzbauer, J.Q. Trojanowski, and V.M. Lee Initiation and synergistic fibrillization of tau and alpha-synuclein Science 300 2003 636 640
17. R. Godemann, J. Biernat, E. Mandelkow, and E.M. Mandelkow Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain FEBS Lett. 454 1999 157 164
18. J.E. Goldman, and S.H. Yen Cytoskeletal protein abnormalities in neurodegenerative diseases Ann. Neurol. 19 1986 209 223
19. T. Gomez-Isla, M.C. Irizarry, A. Mariash, B. Cheung, O. Soto, S. Schrump, J. Sondel, L. Kotilinek, J. Day, M.A. Schwarzschild, J.H. Cha, K. Newell, D.W. Miller, K. Ueda, A.B. Young, B.T. Hyman, and K.H. Ashe Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice Neurobiol. Aging 24 2003 245 258
20. J. Gotz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils Science 293 2001 1491 1495
21. M. Hashimoto, H. LJ, Y. Xia, A. Takeda, A. Sisk, M. Sundsmo, and E. Masliah Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro NeuroReport 10 1999 717 721
22. M. Hashimoto, L.J. Hsu, E. Rockenstein, T. Takenouchi, M. Mallory, and E. Masliah alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells J. Biol. Chem. 277 2002 11465 11472
23. M. Hong, V. Zhukareva, V. Vogelsberg-Ragaglia, Z. Wszolek, L. Reed, B. Miller, D. Geschwind, T. Bird, D. McKeel, A. Goate, J. Morris, K. Wilhelmsen, G. Schellenberg, J. Trojanowski, and V. Lee Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17 Science 282 1998 1914 1917
24. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
25. M. Hutton, C. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J. Kwon, P. Nowotny, P. Heutink, and e. al Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
26. M. Ihara, H. Tomimoto, H. Kitayama, Y. Morioka, I. Akiguchi, H. Shibasaki, M. Noda, and M. Kinoshita Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies J. Biol. Chem. 278 2003 24095 24102
27. T. Ishizawa, P. Mattila, P. Davies, D. Wang, and D.W. Dickson Colocalization of tau and alpha-synuclein epitopes in Lewy bodies J. Neuropathol. Exp. Neurol. 62 2003 389 397
28. J. Jenco, A. Rawlingson, B. Daniels, and A. Morris Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by a and b synucleins Biochemistry 37 1998 4901 4909
29. P.H. Jensen, H. Hager, M.S. Nielsen, P. Hojrup, J. Gliemann, and R. Jakes alpha-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356 J. Biol. Chem. 274 1999 25481 25489
30. G.A. Jicha, E. Lane, I. Vincent, L. Otvos Jr., R. Hoffmann, and P. Davies A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease J. Neurochem. 69 1997 2087 2095
31. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, A. Schindzielorz, M. Okochi, U. Leimer, H. van Der Putten, A. Probst, E. Kremmer, H.A. Kretzschmar, and C. Haass Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain J. Neurosci. 20 2000 6365 6373
32. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, S. Odoy, N. Okamoto, H. Jacobsen, T. Iwatsubo, J.Q. Trojanowski, H. Takahashi, K. Wakabayashi, N. Bogdanovic, P. Riederer, H.A. Kretzschmar, and C. Haass Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model Am. J. Pathol. 159 2001 2215 2225
33. R. Kruger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J. Epplen, L. Schols, and O. Riess Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
34. F.J. Lee, F. Liu, Z.B. Pristupa, and H.B. Niznik Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB J. 15 2001 916 926
35. V.M. Lee, M. Goedert, and J.Q. Trojanowski Neurodegenerative tauopathies Annu. Rev. Neurosci. 24 2001 1121 1159
36. J. Lewis, E. McGowan, J. Rockwood, H. Melrose, P. Nacharaju, M. Van Slegtenhorst, K. Gwinn-Hardy, M. Paul Murphy, M. Baker, X. Yu, K. Duff, J. Hardy, A. Corral, W.L. Lin, S.H. Yen, D.W. Dickson, P. Davies, and M. Hutton Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat. Genet. 25 2000 402 405
37. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
38. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, and L. Mucke Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
39. E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, M. Hashimoto, and L. Mucke beta-Amyloid peptides enhance alpha -synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease Proc. Natl. Acad. Sci.U. S. A. 25 2001 25
40. Y. Muramatsu, R. Kurosaki, H. Watanabe, M. Michimata, M. Matsubara, Y. Imai, and T. Araki Cerebral alterations in a MPTP-mouse model of Parkinson's disease-An immunocytochemical study J. Neural Transm. 110 2003 1129 1144
41. D.D. Murphy, S.M. Rueter, J.Q. Trojanowski, and V.M. Lee Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons J. Neurosci. 20 2000 3214 3220
42. S. Nemoto, K. Takeda, Z.X. Yu, V.J. Ferrans, and T. Finkel Role for mitochondrial oxidants as regulators of cellular metabolism Mol. Cell. Biol. 20 2000 7311 7318
43. M. Neumann, P.J. Kahle, B.I. Giasson, L. Ozmen, E. Borroni, W. Spooren, V. Muller, S. Odoy, H. Fujiwara, M. Hasegawa, T. Iwatsubo, J.Q. Trojanowski, H.A. Kretzschmar, and C. Haass Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies J. Clin. Invest. 110 2002 1429 1439
44. N. Ostrerova, L. Petrucelli, M. Farrer, N. Mehta, P. Alexander, P. Choi, J. Palacino, J. Hardy, and B. Wolozin α-Synuclein shares physical and functional homology with 14-3-3 proteins J. Neurosci. 19 1999 5782 5791
45. N. Ostrerova-Golts, L. Petrucelli, J. Hardy, J. Lee, M. Farrer, and B. Wolozin The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity J. Neurosci. 20 2000 6048 6054
46. S. Paik, H. Shin, J. Lee, C. Chang, and J. Kim Copper(II)-induced self-oligomerization of α-synuclein Biochem. J. 340 1999 821 828
47. S.R. Paik, H.J. Shin, and J.H. Lee Metal-catalyzed oxidation of alpha-synuclein in the presence of copper(II) and hydrogen peroxide Arch. Biochem. Biophys. 378 2000 269 277
48. H.K. Paudel The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase J. Biol. Chem. 272 1997 1777 1785
49. R.G. Perez, J.C. Waymire, E. Lin, J.J. Liu, F. Guo, and M.J. Zigmond A role for alpha-synuclein in the regulation of dopamine biosynthesis J. Neurosci. 22 2002 3090 3099
50. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
51. A.N. Pronin, A.J. Morris, A. Surguchov, and J.L. Benovic Synucleins are a novel class of substrates for G protein-coupled receptor kinases J. Biol. Chem. 275 2000 26515 26522
52. N. Sahara, J. Lewis, M. DeTure, E. McGowan, D.W. Dickson, M. Hutton, and S.H. Yen Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility J. Neurochem. 83 2002 1498 1508
53. M.G. Schlossmacher, M.P. Frosch, W.P. Gai, M. Medina, N. Sharma, L. Forno, T. Ochiishi, H. Shimura, R. Sharon, N. Hattori, J.W. Langston, Y. Mizuno, B.T. Hyman, D.J. Selkoe, and K.S. Kosik Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies Am. J. Pathol. 160 2002 1655 1667
54. N. Sharma, J. Hewett, L.J. Ozelius, V. Ramesh, P.J. McLean, X.O. Breakefield, and B.T. Hyman A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study Am. J. Pathol. 159 2001 339 344
55. R. Sharon, M.S. Goldberg, I. Bar-Josef, R.A. Betensky, J. Shen, and D.J. Selkoe alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins Proc. Natl. Acad. Sci. U. S. A. 98 2001 9110 9115
56. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2 Biochem. J. 336 Pt. 1 1998 241 246
57. E.M. Sigurdsson, J.M. Lee, X.W. Dong, M.J. Hejna, and S.A. Lorens Laterality in the histological effects of injections of amyloid-beta 25-35 into the amygdala of young Fischer rats J. Neuropathol. Exp. Neurol. 56 1997 714 725
58. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy alpha-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
59. H. Snyder, K. Mensah, C. Theisler, J. Lee, A. Matouschek, and B. Wolozin Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function J. Biol. Chem. 278 2003 11753 11759
60. J.M. Souza, B.I. Giasson, V.M. Lee, and H. Ischiropoulos Chaperone-like activity of synucleins FEBS Lett. 474 2000 116 119
61. M. Spillantini, M. Schmidt, L. VM-Y, J. Trojanowski, R. Jakes, and M. Goedert α-Synuclein in Lewy bodies Nature 388 1997 839 840
62. M.G. Spillantini, T.D. Bird, and B. Ghetti Frontotemporal dementia and parkinsonism linked to chromosome 17: a new group of tauopathies Brain Pathol. 8 1998 387 402
63. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa, and M. Goedert α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc. Natl. Acad. Sci. U. S. A. 95 1998 6469 6473
64. P. Strocchi, A. Pession, and B. Dozza Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells J. Cell. Biochem. 88 2003 758 765
65. A. Takashima, K. Noguchi, G. Michel, M. Mercken, M. Hoshi, K. Ishiguro, and K. Imahori Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta Neurosci. Lett. 203 1996 33 36
66. Y. Tatebayashi, T. Miyasaka, D.H. Chui, T. Akagi, K. Mishima, K. Iwasaki, M. Fujiwara, K. Tanemura, M. Murayama, K. Ishiguro, E. Planel, S. Sato, T. Hashikawa, and A. Takashima Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau Proc. Natl. Acad. Sci. U. S. A. 99 2002 13896 13901
67. K. Tsuchiya, K. Ikeda, K. Niizato, S. Watabiki, M. Anno, K. Taki, C. Haga, S. Iritani, and M. Matsushita Parkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases Neuropathology 22 2002 77 84
68. I. Vincent, G. Jicha, M. Rosado, and D.W. Dickson Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain J. Neurosci. 17 1997 3588 3598
69. K. Wakabayashi, S. Engelender, M. Yoshimoto, S. Tsuji, C.A. Ross, and H. Takahashi Synphilin-1 is present in Lewy bodies in Parkinson's disease Ann. Neurol. 47 2000 521 523
70. Y.H. Wang, C.J. Fiol, A.A. DePaoli-Roach, A.W. Bell, M.A. Hermodson, and P.J. Roach Identification of phosphorylation sites in peptides using a gas-phase sequencer Anal. Biochem. 174 1988 537 547
71. Q.M. Wang, C.J. Fiol, A.A. DePaoli-Roach, and P.J. Roach Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation J. Biol. Chem. 269 1994 14566 14574
72. J.Z. Wang, Q. Wu, A. Smith, I. Grundke-Iqbal, and K. Iqbal Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase FEBS Lett. 436 1998 28 34
73. J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atares, V. Llorens, E.G. Tortosa, T. Del Ser, D.G. Munoz, and J.G. De Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173